Novel 5-MeO-DMT Formulation BPL-003

Beckley Psytech Ltd, the private, clinical-stage biopharmaceutical company dedicated to improving the lives of people living with neuropsychiatric disorders by developing effective and rapid-acting psychedelic medicines, today announced the publication of a new paper in The Journal of Psychopharmacology which demonstrates the safety, tolerability and rapid-acting subjective effects of BPL-003, Beckley Psytech’s novel, synthetic, intranasal benzoate salt formulation of 5-MeO-DMT (also known as mebufotenin).

Science, Mysticism and Pyschedelics

Here are two articles exploring the intersection between science, mysticism and psychedelics: here and here.

What does God, quantum mechanics and consciousness have in common?

Theories that try to explain these big metaphysical mysteries fall short, making agnosticism the only sensible stance, this author writes.

What do you think?

In a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.